These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 9144519)

  • 1. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
    Samaniego F; Markham PD; Gallo RC; Ensoli B
    J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
    Chung CH; Chiang J; Jiang CM; Chen YY; Huang CY; Chen PG; Chen YJ
    Neoplasma; 2001; 48(3):192-9. PubMed ID: 11583288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
    Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
    Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
    J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
    Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
    Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
    Gualandris A; Rusnati M; Belleri M; Nelli EE; Bastaki M; Molinari-Tosatti MP; Bonardi F; Parolini S; Albini A; Morbidelli L; Ziche M; Corallini A; Possati L; Vacca A; Ribatti D; Presta M
    Cell Growth Differ; 1996 Feb; 7(2):147-60. PubMed ID: 8822198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U; Rodeck U; Karpinski S; Jost M; Philippou S; Schmiegel W
    Cancer Res; 2001 Oct; 61(19):7282-90. PubMed ID: 11585767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.